Clinical Trials Directory

Trials / Completed

CompletedNCT02062125

Calcinosis in a Single-Center Scleroderma Population

A Prospective, Observational Study of Calcinosis in a Single-Center Population With Scleroderma-Spectrum Disorders

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This is a 10 year study of scleroderma patients with calcinosis 1) to better understand how common and if there are any risk factors for having calcinosis 2\) to identify common complications associated with scleroderma-related calcinosis. .

Detailed description

This is a prospective study of scleroderma- spectrum patients focused on soft tissue calcinosis in order 1) to better understand the risk factors (including clinical/laboratory characteristics, and serology) of calcinosis in the scleroderma-spectrum disorders (limited or diffuse systemic sclerosis with or without overlap of inflammatory arthritis and/or myositis). 2\) view common complications associated with calcinosis. Better understanding of scleroderma calcinosis would lead to other studies that eventually will define better treatment options for this incurable and often disabling complication.

Conditions

Timeline

Start date
2012-10-31
Primary completion
2024-03-15
Completion
2024-03-15
First posted
2014-02-13
Last updated
2024-03-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02062125. Inclusion in this directory is not an endorsement.